Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yong, Seok-Beom | - |
dc.contributor.author | Chung, Jee Young | - |
dc.contributor.author | Song, Yoonsung | - |
dc.contributor.author | Kim, Jaehyun | - |
dc.contributor.author | Ra, Sehee | - |
dc.contributor.author | Kim, Yong-Hee | - |
dc.date.accessioned | 2021-07-30T05:22:57Z | - |
dc.date.available | 2021-07-30T05:22:57Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2019-10 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/4522 | - |
dc.description.abstract | The tumor microenvironmental immune cells (TMICs) consists of myeloid cells (tumor-associated macrophages, dendritic cells, myeloid-derived suppressor cells, etc.) and lymphocytes (T cells and B cells), all of which could be immunologically suppressed through their interactions with cancer cells. Immunological understanding of the tumor microenvironment (TME) has led to great success in the development of clinical cancer immunotherapeutic. The most advanced cancer immunotherapies are chimeric antigen receptor-modified T cells (CAR-T cells) and checkpoint inhibiting antibodies blocking CTLA4, PD-1 and PD-L1. However, many hurdles remain that should be addressed for improved therapeutic efficacy and reduced side effects such as cytokine release syndrome and patient-death. In recent decades, nanoparticles have been demonstrated as an efficient drug delivery tool due to their ease of modification, biocompatibility and intrinsic tumor targeting effect, and also been applied for cancer immunotherapy. In this review, we briefly introduce the immunosuppressive functions of TMICs and review recent advances in the development of TMIC-targeted nanotherapeutics for cancer immunotherapy. Tumor-associated macrophage (TAM)-targeted systems have shown to deplete or re polarize macrophages to M1 state for anti-tumoral immune responses. Tumor-infiltrating T cell (TIT)-targeted strategies have provided the activation of effector T cells and suppression of regulatory T cells in tumor, overcoming the current hurdles of single regimen checkpoint inhibitors. Lastly, recent studies on dendritic cell-targeted mRNA vaccination are discussed and the future perspectives of nano-immunotherapeutic for next-generation of cancer immunotherapy is emphasized. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.title | Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Hee | - |
dc.identifier.doi | 10.1016/j.biomaterials.2019.119401 | - |
dc.identifier.scopusid | 2-s2.0-85071700816 | - |
dc.identifier.wosid | 000484648300022 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.219 | - |
dc.relation.isPartOf | BIOMATERIALS | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 219 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | REGULATORY T-CELLS | - |
dc.subject.keywordPlus | IN-VIVO DELIVERY | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | INFILTRATING MACROPHAGES | - |
dc.subject.keywordPlus | HYBRID NANOPARTICLES | - |
dc.subject.keywordPlus | HEME OXYGENASE-1 | - |
dc.subject.keywordPlus | MESSENGER-RNA | - |
dc.subject.keywordPlus | LYMPH-NODE | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | ANTITUMOR | - |
dc.subject.keywordAuthor | Nano-immunotherapeutic | - |
dc.subject.keywordAuthor | Tumor microenvironmental immune cells-targeted cancer immunotherapy | - |
dc.subject.keywordAuthor | Tumor-associated macrophage-targeted nano-immunotherapeutics | - |
dc.subject.keywordAuthor | Tumor-infiltrating T cell-targeted nano-immunotherapeutics | - |
dc.subject.keywordAuthor | Tumor-associated dendritic cell-targeted nano-immunotherapeutics | - |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S0142961219305009 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.